Skip to content
The tide has been rising in biotech investment in 2024—though it has not lifted all boats equally. While the volume of investment improved in […]
BIO Investor Forum opens with encouraging news on financing Read More »
Colorado’s efforts to impose price controls on prescription drugs are preempted by federal law, according to a legal brief by the Biotechnology Innovation Organization
Colorado price-setting board conflicts with federal law, BIO tells court Read More »
Food and Drug Administration (FDA) inaction on patents for drug delivery devices has been troubling drug manufacturers for 20 years, and the situation is
Sen. Cassidy calls on FDA to act, not abdicate, on drug device patents Read More »
As Claudia Sheinbaum became Mexico’s president on Oct. 1, a bipartisan letter from 21 American Congress members called on U.S. officials to resolve the
As Mexico changes presidents, House members urge action on corn ban Read More »
During a busy week in Congress, House legislation to support drug development for pediatric rare diseases moved forward with bipartisan support, and a Senate
Capitol Hill update: House advances PPRV reauthorization, Senate reviews IRA Read More »
Members of Congress discussed legislation to block proposed federal rules that would regulate growth of genetically engineered crops on wildlife refuges during a Sept.
House members seek to block new wildlife refuge rules regarding GE crops Read More »
Market concentration allows pharmacy benefit managers (PBMs) to siphon off funds from our health care system while increasing costs to patients and reducing access
House hearing delves into antitrust problems of PBMs Read More »
The U.S. Department of Agriculture began field safety trials of a vaccine to protect dairy cattle from avian flu, Agriculture Secretary Tom Vilsack said.
USDA testing vaccine to protect cows from bird flu Read More »
Drug price controls in the Inflation Reduction Act (IRA) involve unconstitutional coercion and will destroy innovation in transformational treatments that save patients’ lives, the
BIO files amicus brief challenging IRA drug price controls Read More »
Members of the public shared emotional stories about how practices by pharmacy benefit managers (PBMs) increase the cost of drugs, reduce patient access, and
Emotional testimonies expose harmful impact of PBMs at FTC hearing Read More »
